Inventors list |
Assignees list |
Classification tree browser |
Top 100 Inventors |
Top 100 Assignees |
Adhya
Saibal Adhya, Bangalore IN
| Patent application number | Description | Published |
|---|---|---|
| 20090037763 | Systems and Methods for Providing IIP Address Stickiness in an SSL VPN Session Failover Environment - The SSL VPN session failover solution of the appliance and/or client agent described herein provides an environment for handling IP address assignment and end point re-authorization upon failover. The appliances may be deployed to provide a session failover environment in which a second appliance is a backup to a first appliance when a failover condition is detected, such as failure in operation of the first appliance. The backup appliance takes over responsibility for SSL VPN sessions provided by the first appliance. In the failover environment, the first appliance propagates SSL VPN session information including user IP address assignment and end point authorization information to the backup appliance. The backup appliance maintains this information. Upon detection of failover of the first appliance, the backup appliance activates the transferred SSL VPN session and maintains the user assigned IP addresses. The backup appliance may also re-authorize the client for the transferred SSL VPN session. | 02-05-2009 |
| 20090037998 | Systems and Methods for Authorizing a Client in an SSL VPN Session Failover Environment - The SSL VPN session failover solution of the appliance and/or client agent described herein provides an environment for handling IP address assignment and end point re-authorization upon failover. The appliances may be deployed to provide a session failover environment in which a second appliance is a backup to a first appliance when a failover condition is detected, such as failure in operation of the first appliance. The backup appliance takes over responsibility for SSL VPN sessions provided by the first appliance. In the failover environment, the first appliance propagates SSL VPN session information including user IP address assignment and end point authorization information to the backup appliance. The backup appliance maintains this information. Upon detection of failover of the first appliance, the backup appliance activates the transferred SSL VPN session and maintains the user assigned IP addresses. The backup appliance may also re-authorize the client for the transferred SSL VPN session. | 02-05-2009 |
Saibal Kumar Adhya, Bangalore IN
| Patent application number | Description | Published |
|---|---|---|
| 20090193129 | Systems and Methods for Fine Grain Policy Driven Cookie Proxying - The present solution enables a client that is not configured to use cookies to access resources of the server that uses cookies for communications with the clients. An intermediary deployed between a client and a server intercepts and modifies transmissions between the client and the server to compensate for the mismatch in configuration of the cookies between the client and the server. The present disclosure relates to a method for managing cookies by an intermediary for a client. An intermediary receives a response from a server to a request of a client. The response may comprise a uniform resource locator (URL) and a cookie. The intermediary may modify the response by removing the cookie from the response and inserting a unique client identifier into the URL. The intermediary may store the removed cookie in association with the unique client identifier and forward the modified response to the client. | 07-30-2009 |
| 20090193498 | SYSTEMS AND METHODS FOR FINE GRAIN POLICY DRIVEN CLIENTLESS SSL VPN ACCESS - The present disclosure provides solutions that may enable an enterprise providing services to a number of clients to determine whether to establish a client based SSL VPN session or a clientless SSL VPN session with a client based on an information associated with the client. An intermediary establishing SSL VPN sessions between clients and servers may receive a request from a client to access a server. The intermediary may identify a session policy based on the request. The session policy may indicate whether to establish a client based SSL VPN session or clientless SSL VPN session with the server. The intermediary may determine, responsive to the policy, to establish a clientless or client based SSL VPN session between the client and the server. | 07-30-2009 |
| 20090199285 | Systems and Methods for For Proxying Cookies for SSL VPN Clientless Sessions - The present application enables the enterprise to configure various policies to address various subsets of the traffic based on various information relating the client, the server, or the details and nature of the interactions between the client and the server. An intermediary deployed between clients and servers may establish an SSL VPN session between a client and a server. The intermediary may receiving a response from a server to a request of a client via the clientless SSL VPN session. The response may comprise one or more cookies. The intermediary may identify an access profile for the clientless SSL VPN session. The access profile may identify one or more policies for proxying cookies. The intermediary may determine, responsive to the one or more policies of the access profile, whether to proxy or bypass proxying for the client the one or more cookies. | 08-06-2009 |
Samit Adhya, West Bengal IN
| Patent application number | Description | Published |
|---|---|---|
| 20100168213 | Protein-coding RNA to correct mitochondrial dysfunction - The present invention provides compositions and methods for using correctional RNA, with a proteinaceous carrier, to stimulate respiration of the cells, tissues, organs or the whole organism of normal or diseased subjects. In one embodiment of the invention, the signal-tagged correctional RNA is one or more protein-coding RNAs (pcRNA) that encode one or more of human mitochondrial proteins. The invention specifically provides a broad-spectrum formulation applicable to a wide variety of disorders that are associated with mitochondrial mutations. | 07-01-2010 |
Sancar Adhya, Gaithersburg, MD US
| Patent application number | Description | Published |
|---|---|---|
| 20100022402 | Methods and Compositions for the In Vitro High-Throughput Detection of Protein/Protein Interactions - The present invention relates to methods and compositions for the identification and/or assessment of protein/protein interactions, and in particular to methods and compositions for accomplishing the high-throughput detection of interactions of proteins displayed on the surfaces of lambdoid bacteriophage particles. | 01-28-2010 |
Sankar Adhya, Gaithersburg, MD US
| Patent application number | Description | Published |
|---|---|---|
| 20090155768 | Reporter plasmid phage packaging system for detection of bacteria - The invention is related to a transducing particle that comprises a bacteriophage coat and a DNA core that comprises plasmid DNA comprising: a) a host-specific bacteriophage packaging site wherein the packaging site is substantially in isolation from sequences naturally occurring adjacent thereto in the bacteriophage genome, b) a reporter gene, c) a bacteria-specific promoter operably linked to said reporter gene, d) a bacteria-specific origin of replication, and optionally e) an antibiotic resistance gene. The invention includes phage transducing particles, methods of making transducing particles, and methods of using the transducing particles in bacterial detection. | 06-18-2009 |
| 20110086338 | Bacteriophage/Quantum-Dot (Phage-QD) Nanocomplex to Detect Biological Targets in Clinical and Environmental Isolates - The invention is related to a non-biotinylated bacteriophage that comprises a nucleic acid sequence encoding a biotinylation domain, a complex that comprises a biotinylated bacteriophage and a biotin-specific ligand conjugated bioconjugate, and a method of detecting a bacterial cell in a sample comprising contacting the sample with a non-biotinylated bacteriophage that comprises a nucleic acid sequence encoding a biotinylation domain, wherein the bacteriophage is specific to the bacterial cell. | 04-14-2011 |